The State of Vaping in America: Insights from the U.S. State Vaping Index

The Consumer Choice Center has recently published its second U.S. State Vaping Index, evaluating vaping policies across all 50 states and the District of Columbia. The findings are particularly revealing, highlighting significant disparities in how states regulate vaping as compared to traditional tobacco products.

Top Performing States in Vaping Policy

Among the 51 jurisdictions analyzed, three states stand out with an impressive A+ rating for their evidence-based approach to vaping policy: Alaska, North Dakota, and Tennessee. These states are recognized for their balanced and informed stance that empowers consumers while leveraging vaping as a harm-reduction tool.

In addition to these top three, several other states demonstrated commendable policies, including:

• Arizona
• Michigan
• Mississippi
• Missouri
• Montana
• Texas
• Alabama
• Arkansas
• Oklahoma
• Wisconsin

States with Restrictive Vaping Policies

On the flip side, the index also revealed that a dozen states have adopted overly restrictive vaping policies. Notable examples include:

• Utah: 0 points
• California: 5 points (second to last)
• Vermont: 10 points
• Oregon, New York, New Jersey, Nebraska, Massachusetts, Illinois, Hawaii, D.C., Colorado: All at 15 points

The increase in low scores marks a doubling of states with unfavorable rankings since the 2020 edition of the Vaping Index.

The Consequences of Restrictive Policies

According to Emil Panzaru, research director for the Consumer Choice Center, “Vaping saves lives.” A hypothetical scenario posits that if every smoker in the U.S. switched to vaping over a decade, it could prevent an estimated 6.6 million premature deaths.

However, Panzaru emphasizes a critical issue: policymakers often fail to recognize vaping as a viable harm-reduction alternative to traditional tobacco products. Numerous states impose severe regulations that equate vaping with smoking by:

• Implementing flavor bans
• Incorporating higher taxes on vaping products than on combustible cigarettes
• Mandating complex registries for vape products
• Banning online sales

These measures are not only detrimental to consumer choice but also encourage black market activity, leading to a confusing landscape of laws that contradict contemporary public health practices worldwide.

A Call for Evidence-Based Approaches

The purpose of the U.S. Vaping Index extends beyond mere rankings; it aims to educate consumers about local vaping policies and spotlight the need for informed, rational legislation. The index analyzes five critical factors:

1. Whether the state considers vapes to be tobacco products
2. State-level vaping flavor restrictions
3. Requirements for state registries mirroring FDA databases
4. Additional excise taxes on vaping
5. Presence or absence of online sales bans

Panzaru insists on the importance of aligning legislative actions with scientific research. He cites findings from Public Health England confirming that vaping is 95% safer than smoking combustible tobacco. Additionally, a study published in the New England Journal of Medicine underscores that vaping is twice as effective as nicotine replacement therapies, such as patches and gums, in helping individuals quit smoking.

Moreover, a comprehensive review of 15 studies indicates minimal evidence of a “gateway effect” whereby vaping leads youth to experiment with smoking or other substances.

Learning from International Examples

Panzaru concludes with a call to action for state authorities to adopt evidence-based policies similar to those in Sweden, recognized as the first nation in Europe to achieve a smoke-free status due to its acceptance of vaping as a harm-reduction alternative.

Conclusion

The **U.S. State Vaping Index** highlights the ongoing need for rational, science-based vaping regulations that prioritize public health and consumer choice. As evidence mounts regarding the safety and effectiveness of vaping versus conventional smoking, states must reconsider their current policies and align them with proven research.